Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nexavar
Pharma
ESMO: Merck's Keytruda-Lenvima flop hands rivals a win
An unusually strong Lenvima monotherapy showing might have cost Merck its case. But it's not all bad news.
Angus Liu
Sep 8, 2022 1:44pm
FDA accepts AZ's application for tremelimumab in liver cancer
Apr 25, 2022 9:29am
AstraZeneca's blockbuster Imfinzi flunks cervical cancer trial
Mar 24, 2022 9:26am
Exelixis axes Cabometyx-Tecentriq combo in liver cancer
Mar 15, 2022 11:05am
Bayer poaches GSK exec to lead oncology business
Feb 7, 2022 10:39am
Merck's Keytruda charts murky FDA path in liver cancer
Jan 18, 2022 5:00pm
